DELL'OSTE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 5.783
EU - Europa 3.650
AS - Asia 1.470
AF - Africa 122
SA - Sud America 62
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.144
Nazione #
US - Stati Uniti d'America 5.704
IT - Italia 1.284
CN - Cina 721
IE - Irlanda 471
SE - Svezia 392
DE - Germania 277
GB - Regno Unito 210
FR - Francia 207
AT - Austria 189
FI - Finlandia 149
JP - Giappone 144
UA - Ucraina 135
KR - Corea 127
VN - Vietnam 127
IN - India 90
PL - Polonia 90
HK - Hong Kong 67
SN - Senegal 62
CA - Canada 55
SG - Singapore 55
AU - Australia 47
NL - Olanda 45
BE - Belgio 42
GR - Grecia 26
TW - Taiwan 26
ES - Italia 23
IL - Israele 23
IR - Iran 20
MX - Messico 20
UG - Uganda 20
TR - Turchia 19
ZA - Sudafrica 18
BR - Brasile 17
DK - Danimarca 17
RU - Federazione Russa 14
CO - Colombia 13
NO - Norvegia 13
IQ - Iraq 12
RO - Romania 11
PH - Filippine 10
SI - Slovenia 10
CH - Svizzera 9
TN - Tunisia 9
CL - Cile 8
NZ - Nuova Zelanda 8
PE - Perù 8
PK - Pakistan 8
AR - Argentina 7
HR - Croazia 7
CZ - Repubblica Ceca 5
PT - Portogallo 5
EC - Ecuador 4
LU - Lussemburgo 4
PR - Porto Rico 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
MA - Marocco 3
NG - Nigeria 3
RS - Serbia 3
ZM - Zambia 3
BD - Bangladesh 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
EU - Europa 2
GY - Guiana 2
ID - Indonesia 2
JO - Giordania 2
MU - Mauritius 2
MY - Malesia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
EG - Egitto 1
GH - Ghana 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
NP - Nepal 1
SM - San Marino 1
UY - Uruguay 1
YE - Yemen 1
Totale 11.144
Città #
Chandler 1.127
Dublin 467
Beijing 319
Torino 266
Fairfield 262
Houston 257
Ann Arbor 239
Vienna 180
Ashburn 175
Nyköping 153
Woodbridge 153
Villeurbanne 144
Jacksonville 141
Wilmington 131
Princeton 126
Medford 122
Sovicille 115
Redwood City 114
Dearborn 109
Pisa 106
Seattle 104
Cambridge 103
Dong Ket 91
Turin 78
Warsaw 78
Guangzhou 62
Boston 57
Fremont 56
Rome 55
New York 53
Los Angeles 47
Milan 39
Washington 36
Shanghai 31
Norwalk 30
Tokyo 29
San Diego 27
Brussels 25
Hebei 25
Higashiayase 25
Boardman 24
Taipei 24
Maddaloni 22
Helsinki 21
Pittsburgh 21
Rochester 21
Phoenix 20
Hangzhou 19
Nanjing 19
Singapore 19
Kampala 18
London 18
Wuhan 17
Hefei 16
Orange 16
Baltimore 15
Elk Grove Village 15
Gongju 15
Piemonte 15
Philadelphia 14
San Mateo 14
Seoul 14
Thebes 14
Dallas 13
Novara 13
Toronto 13
Bogotá 12
Central 12
Ipswich 12
Munich 12
Utrecht 12
Chicago 11
Falls Church 11
Hamburg 11
Hanover 11
Melbourne 11
San Mauro Torinese 11
Birmingham 10
Changsha 10
Fossano 10
San Francisco 10
Berlin 9
Blackwood 9
Casteggio 9
Chengdu 9
Florence 9
Johannesburg 9
Kunming 9
Leeds 9
Lincoln 9
Aarhus 8
Bethesda 8
Boffalora sopra Ticino 8
Erlangen 8
Jinan 8
Oslo 8
Ottawa 8
Santiago 8
Silver Spring 8
Tel Aviv 8
Totale 6.534
Nome #
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 330
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 310
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 259
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor 242
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 216
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the transcriptional regulation of MICA and PVR/CD155 expression. 215
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 209
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 197
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 175
The US16 gene of human cytomegalovirus is equired for efficient viral infection of endothelial and epithelial cells.[Bronzini M.*, Luganini A.* co-first author] 168
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 168
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 167
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 165
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 163
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 162
The intracellular DNA Sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication [*Gariano GR, *Dell'Oste V*, co-first authors] 156
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 155
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 152
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 151
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling. 147
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 141
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer 135
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 135
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 130
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 125
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 125
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 123
Strigolactone analogs are promising antiviral agents against Herpesviruses 121
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 117
Past and ongoing adaptation of human cytomegalovirus to its host. 116
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 115
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 115
The interferon-inducibel IFI16 gene is a restriction factor for Human cytomegalovirus replication 114
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 113
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus 112
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 112
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 111
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 109
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 105
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 101
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 100
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 100
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 98
Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression 97
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 95
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 94
Sviluppo ed utilizzo di un saggio cellulare ad alta resa per l’identificazione di inibitori dell’espressione delle oncoproteine E6 ed E7 di HPV-16 88
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 88
The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication 87
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 87
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 86
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 86
High beta-HPV DNA Loads and Strong Seroreactivity Are Present in Epidermodysplasia Verruciformis 83
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 83
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 83
Otcome del neonato con infezione congenita da citomegalovirus. Correlazione con l'infezione materna e le caratteristiche cliniche neonatali 83
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 81
Tuning the Orchestra: HCMV vs. Innate Immunity. 81
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 81
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models 79
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 79
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 79
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 79
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 77
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 76
Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells 76
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 75
Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations 73
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 73
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 72
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 71
CLINICAL SIGNIFICANCE OF ANTI-IFI16 AUTOANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES 68
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 68
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 68
Mutazioni e polimorfismi genetici nell’Epidermodisplasia verruciforme: un modello di carcinogenesi. 66
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 65
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 65
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 65
Defective Fas function and variation of Perforin gene in a patient with Epidermodysplasia Verruciformis 64
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 63
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene 63
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 62
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 62
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 61
Characterization of a patient with Epidermodysplasia verruciformis carrying defective Fas function and variation of perforin gene in the absence of EVER gene mutations. 59
Human Cytomegalovirus induces redistribution of the interferon inducible protein IFI16 from nucleus to cytoplasm 57
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 57
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 57
45th International Herpesvirus Workshop 57
Virologic, immunologic and clinical characterization of a patient with Epidermodysplasia verruciformis. 55
Targeting PAD-mediated citrullination to treat human papillomavirus infections 55
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 54
Elucidation of natural beta-HPV-host interactions in organotypic cultures and skin biopsies from Epidermodysplasia verruciformis patients. 53
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 53
No indications for HPV involvement in the hypertrophic skin lesions of a Darier disease case without ATP2A2 gene mutations 52
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding 51
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 50
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 49
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 49
The interferon-inducible DNa-sensor protein IFI16: a key player in the antiviral response. 48
Totale 10.568
Categoria #
all - tutte 29.919
article - articoli 0
book - libri 0
conference - conferenze 16.382
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019268 0 0 0 0 0 0 0 0 0 0 191 77
2019/20201.408 43 57 77 165 76 240 138 105 126 154 102 125
2020/20211.447 107 80 77 76 122 125 157 98 136 169 90 210
2021/20221.687 87 96 102 160 90 62 81 88 65 115 442 299
2022/20233.164 202 168 70 360 339 746 162 262 481 95 165 114
2023/20241.276 193 202 111 69 149 205 99 103 24 118 3 0
Totale 11.546